This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Pharmaceuticals & Medicine Manufacturing

NEW YORK, Nov. 20, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue

Global Pharmaceuticals & Medicine Manufacturing

Global Pharmaceuticals & Medicine Manufacturing

This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms, including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented between prescription-based (or ethical) products and over-the-counter medications. The products are predominantly distributed via wholesalers and are then sold via pharmacies or distributed in hospitals.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.



Industry Definition

Main Activities

Similar Industries

Additional Resources

INDUSTRY PERFORMANCEExecutive SummaryKey External DriversCurrent PerformanceIndustry OutlookIndustry Life Cycle


Supply Chain

Products & Services

Demand Determinants

Major Markets

International Trade

Business Locations

COMPETITIVE LANDSCAPEMarket Share ConcentrationKey Success FactorsCost Structure BenchmarksBasis of CompetitionBarriers to EntryIndustry Globalization


OPERATING CONDITIONSCapital IntensityTechnology & SystemsRevenue VolatilityRegulation & PolicyIndustry Assistance


Industry Data

Annual Change

Key Ratios



Pfizer Inc.

To order this report:

Drug_and_Medication Industry: Global Pharmaceuticals & Medicine Manufacturing

Nicolas BombourgReportlinkerEmail: US: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs